Heart transplantation in a 68-year-old patient with senile systemic amyloidosis

23Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Senile systemic amyloidosis (SSA) results from deposition, predominantly in the heart, of amyloid fibrils derived from wild-type transthyretin (TTR) molecules. Cardiac autopsies indicate that SSA progressively increases in subjects 80 years of age and older. However, only a few cases of patients with SSA and cardiac failure have been recognized by cardiac biopsies during life. Here, we report a case of heart transplantation in a 68-year-old male patient with SSA. After cardiopulmonary resuscitation in October 1998, he underwent complete evaluation. Myocardial biopsies revealed the presence of amyloid deposition. Immunohistochemical staining of the amyloid indicated TTR. Genomic DNA analysis of the TTR exons did not result in any identification of a mutation. In 2001, heart transplantation was performed because progressive heart failure occurred. At the 1-year follow-up, no amyloid deposits were found in the donor heart. At the 2-year follow-up, the patient's physical and mental health was excellent. We conclude that heart transplantation can be an effective treatment in progressive heart failure due to SSA. Copyright © Blackwell Munksgaard 2005.

Cite

CITATION STYLE

APA

Fuchs, U., Zittermann, A., Suhr, O., Holmgren, G., Tenderich, G., Minami, K., & Koerfer, R. (2005). Heart transplantation in a 68-year-old patient with senile systemic amyloidosis. American Journal of Transplantation, 5(5), 1159–1162. https://doi.org/10.1111/j.1600-6143.2005.00805.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free